Skip to main content

Table 4 Multivariate analysis of LRFS on quality of life of QLQ-C30 among 501 patients with nasopharyngeal carcinoma

From: Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

 

HR

95%CI

P

Age

1.583

0.582–4.302

0.368

Gender

1.017

0.300–3.450

0.978

Marriage

0.479

0.099–2.320

0.360

Education

1.337

0.852–2.098

0.206

Smoking history

1.455

0.512–4.139

0.482

Alcohol history

1.086

0.480–2.458

0.843

T stage

1.267

0.361–4.449

0.712

N stage

1.604

0.616–4.172

0.333

Pre-treatment EBV DNA

1.221

0.491–3.035

0.667

Post-treatment EBV DNA

3.093

0.881–10.857

0.078

Cognitive functioning

0.971

0.951–0.990

0.004

  1. Abbreviations: LRFS Loco regional recurrent free survival, HR Harsard ratio
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us